We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

54 hedge funds and large institutions have $72M invested in Abeona Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

73% more capital invested

Capital invested by funds: $41.6M → $72M (+$30.4M)

38% more funds holding

Funds holding: 39 → 54 (+15)

1.49% more ownership

Funds ownership: 0% → 1.49% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less call options, than puts

Call options by funds: $126K | Put options by funds: $138K

Holders
54
Holders Change
+15
Holders Change %
+38.46%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
17
Reduced
9
Closed
4
Calls
$126K
Puts
$138K
Net Calls
-$12K
Net Calls Change
-$77K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$12.2M
2
BBA
Baker Bros. Advisors
New York
+$9.91M
3
RCM
RA Capital Management
Massachusetts
+$7.16M
4
KCM
Knoll Capital Management
Florida
+$6.26M
5
CAM
Cormorant Asset Management
Massachusetts
+$3.13M

Top Sellers

Rank Fund Capital Flow
1
SFM
Soros Fund Management
New York
-$3.54M
2
PA
Perceptive Advisors
New York
-$3.09M
3
RA
Royce & Associates
New York
-$392K
4
Goldman Sachs
Goldman Sachs
New York
-$354K
5
RI
RTW Investments
New York
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$11.4M +$6.26M +40,000 +74%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$9.46M +$12.2M +78,000 New
BBA
3
Baker Bros. Advisors
New York
$8.17M +$9.91M +63,308 +1,557%
RCM
4
RA Capital Management
Massachusetts
$5.54M +$7.16M +45,714 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.43M +$2.17M +13,828 +61%
SFM
6
Soros Fund Management
New York
$4.35M -$3.54M -22,619 -39%
PA
7
Perceptive Advisors
New York
$4.08M -$3.09M -19,755 -37%
NC
8
Nexthera Capital
New York
$2.76M +$1.55M +9,879 +77%
HCM
9
Highbridge Capital Management
New York
$2.68M +$1.8M +11,466 +108%
CAM
10
Cormorant Asset Management
Massachusetts
$2.42M +$3.13M +20,000 New
Millennium Management
11
Millennium Management
New York
$2.04M +$173K +1,104 +7%
OM
12
Opaleye Management
Massachusetts
$1.94M +$1.88M +12,000 +300%
KAM
13
Kavi Asset Management
New York
$1.77M +$1.89M +12,092 +478%
CHP
14
Castle Hook Partners
New York
$1.7M +$2.19M +13,992 New
RA
15
Royce & Associates
New York
$1.51M -$392K -2,504 -17%
BIT
16
BlackRock Institutional Trust
California
$982K +$826K +5,275 +187%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$928K +$448K +2,858 +60%
Wellington Management Group
18
Wellington Management Group
Massachusetts
$845K +$1.09M +6,972 New
MCM
19
Moore Capital Management
New York
$728K +$940K +6,000 New
Jennison Associates
20
Jennison Associates
New York
$686K +$886K +5,656 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$375K +$315K +2,013 +187%
DCM
22
DAFNA Capital Management
California
$372K +$481K +3,072 New
CT
23
Cambridge Trust
Massachusetts
$317K – – –
Allianz Asset Management
24
Allianz Asset Management
Germany
$236K +$304K +1,943 New
Northern Trust
25
Northern Trust
Illinois
$213K +$124K +791 +82%
1
2 3

ABEO Hedge Fund Activity: Q4 2016 in Review

54 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2016, worth a combined $72M — up 73% from $41.6M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ABEO positions and 4 closed out — a net gain of 16 holders — while 17 added to existing stakes and 9 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $12.2M. The largest seller was Soros Fund Management, cutting an estimated $3.54M.

  • 54 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2016, up from 39 in Q3 2016.
  • Funds reported $72M of Abeona Therapeutics stock for Q4 2016, up 73% quarter-over-quarter.
  • 20 funds opened new Abeona Therapeutics positions in Q4 2016 and 4 closed out, a net change of +16 holders.
  • The largest Abeona Therapeutics buyer in Q4 2016 was Adage Capital Partners, an estimated $12.2M added.
  • The largest Abeona Therapeutics seller in Q4 2016 was Soros Fund Management, an estimated $3.54M sold.

Based on aggregated 13F filings for Q4 2016.